Mironid raises £34m Series B with SNIB pariticipation
Mironid has raised a £34 million ($46 million) Series B funding round to advance clinical development of its ADPKD treatment. The financing...
Mironid has raised a £34 million ($46 million) Series B funding round to advance clinical development of its ADPKD treatment. The financing...